Vital Therapies, which is developing bio-artificial liver cells for treatment of acute liver failure, raised $54 million by offering 4.5 million shares at $12, below the downwardly revised range of $13 to $15. The company had originally filed to offer 4.4 million shares at a range of $16 to $18 but postponed in November 2013. Vital Therapies plans to list on the NASDAQ under the symbol VTL. BofA Merrill Lynch and Credit Suisse acted as lead managers on the deal.
Zoosk, an online dating platform with the top grossing dating app and 26 million members, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. The San Francisco, CA-based company, which was founded in 2007 and booked $178 million in sales for the fiscal year ended December 31, 2013, plans to list on the NYSE under the symbol ZSK. BofA Merrill Lynch, Citi and RBC Capital Markets are the joint bookrunners on the deal. No pricing terms were disclosed.
Microlin Bio, a development stage diagnostic and therapeutics company focusing on microRNA and its role in oncology, raised the proposed deal size for its upcoming IPO and changed underwriters on Wednesday. The New York, NY-based company now plans to raise $30 million by offering 2.7 million shares at a price range of $10 to $12. It had previously filed to offer 3.6 million shares at a range of $6 to $8. At the midpoint of the revised range, Microlin Bio will raise 20% greater proceeds than previously anticipated.
The amendment listed Brean Capital and Summer Street Research Partners as the joint bookrunners, replacing Sunrise Securities. Microlin no longer plans to tap one of its Directors as CFO and announced that it is searching for another person to fill the position. The company plans to list on the NASDAQ under the symbol MCLB. A pricing date has not been set.
Leju Holdings, which operates real estate information and e-commerce websites in China, lowered the proposed deal size for its upcoming IPO on Wednesday. The Beijing, China-based company now plans to raise $110 million by offering 10 million shares at a price range of $10 to $12. The company had previously filed to offer 17.7 million shares at the same range. At the midpoint, it will raise 44% fewer proceeds than previously anticipated.
Leju Holdings, which was founded in 2008 and booked $335 million in sales for the 12 months ended December 31, 2013, plans to list on the NYSE under the symbol LEJU. It initially filed confidentially on January 21, 2014. Credit Suisse and J.P. Morgan are the joint bookrunners on the deal. It is expected to price during the week of April 14, 2014.